Hey #AACR26, check out Session PO.CL05.09 - Inflammation, Immunity, and Cancer (Section 45) from 2-5pm PDT to see our team’s research in “Nrf2 as a therapeutic target to improve T cell function in muscle invasive bladder cancer (MIBC)” https://t.co/5Cjecf79XU